Celgene's (NASDAQ: CELG) Otezla received FDA orphan drug designation for treatment of pediatric patients with ulcerative ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE